The Chronic Care Policy Alliance (CCPA) recently submitted comments to Senate HELP Committee Chairman Bill Cassidy on the discussion draft of the 340B Drug Pricing Integrity and Affordability for Patients Act.
In the letter, CCPA expresses support for reforms designed to strengthen the 340B program’s accountability while preserving its role in supporting safety-net providers and underserved patients. CCPA highlights provisions that would better ensure 340B savings reach patients, increase transparency through public reporting requirements, and enhance program integrity through stronger oversight of participating entities and intermediaries. The organization emphasizes that maintaining public trust in the program requires clear patient-focused standards, meaningful transparency, and safeguards that help ensure 340B resources are used consistent with the program’s original mission.